The National Institutes of Health chronic prostatitis symptom index: development and validation of a new outcome measure. Chronic Prostatitis Collaborative Research Network
- PMID: 10411041
- DOI: 10.1016/s0022-5347(05)68562-x
The National Institutes of Health chronic prostatitis symptom index: development and validation of a new outcome measure. Chronic Prostatitis Collaborative Research Network
Abstract
Purpose: Chronic abacterial prostatitis is a syndrome characterized by pelvic pain and voiding symptoms, which is poorly defined, poorly understood, poorly treated and bothersome. Research and clinical efforts to help men with this syndrome have been hampered by the absence of a widely accepted, reliable and valid instrument to measure symptoms and quality of life impact. We developed a psychometrically valid index of symptoms and quality of life impact for men with chronic prostatitis.
Materials and methods: We conducted a structured literature review of previous work to provide a foundation for the new instrument. We then conducted a series of focus groups comprising chronic prostatitis patients at 4 centers in North America, in which we identified the most important symptoms and effects of the condition. The results were used to create an initial draft of 55 questions that were used for formal cognitive testing on chronic prostatitis patients at the same centers. After expert panel review formal validation testing of a revised 21-item draft was performed in a diverse group of chronic prostatitis patients and 2 control groups of benign prostatic hyperplasia patients and healthy men. Based on this validation study, the index was finalized.
Results: Analysis yielded an index of 9 items that address 3 different aspects of the chronic prostatitis experience. The primary component was pain, which we captured in 4 items focused on location, severity and frequency. Urinary function, another important component of symptoms, was captured in 2 items (1 irritative and 1 obstructive). Quality of life impact was captured with 3 items about the effect of symptoms on daily activities. The 9 items had high test-retest reliability (r = 0.83 to 0.93) and internal consistency (alpha = 0.86 to 0.91). All but the urinary items discriminated well between men with and without chronic prostatitis.
Conclusions: The National Institutes of Health chronic prostatitis symptom index provides a valid outcome measure for men with chronic prostatitis. The index is psychometrically robust, easily self-administered and highly discriminative. It was formally developed and psychometrically validated, and may be useful in clinical practice as well as research protocols.
Similar articles
-
A review of the development and validation of the National Institutes of Health Chronic Prostatitis Symptom Index.Urology. 2002 Dec;60(6 Suppl):14-8; discussion 18-9. doi: 10.1016/s0090-4295(02)02296-3. Urology. 2002. PMID: 12521581 Review.
-
Prevalence of prostatitis-like symptoms in a population based study using the National Institutes of Health chronic prostatitis symptom index.J Urol. 2001 Mar;165(3):842-5. J Urol. 2001. PMID: 11176483
-
National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI) symptom evaluation in multinational cohorts of patients with chronic prostatitis/chronic pelvic pain syndrome.Eur Urol. 2013 May;63(5):953-9. doi: 10.1016/j.eururo.2012.10.042. Epub 2012 Nov 2. Eur Urol. 2013. PMID: 23141933
-
National institutes of Health Chronic Prostatitis Symptom Index for Japanese men.Urology. 2002 Jul;60(1):74-7. doi: 10.1016/s0090-4295(02)01636-9. Urology. 2002. PMID: 12100927
-
The impact of chronic prostatitis/chronic pelvic pain syndrome on patients.World J Urol. 2003 Jun;21(2):86-9. doi: 10.1007/s00345-003-0331-6. Epub 2003 Apr 2. World J Urol. 2003. PMID: 12682773 Review.
Cited by
-
α-Blockers for the Treatment of Chronic Prostatitis/Chronic Pelvic Pain Syndrome: An Update on Current Clinical Evidence.Rev Urol. 2012;14(3-4):56-64. Rev Urol. 2012. PMID: 23526487 Free PMC article.
-
Lower urinary tract symptoms associated with prostatitis.Can Urol Assoc J. 2012 Oct;6(5 Suppl 2):S133-5. doi: 10.5489/cuaj.12201. Can Urol Assoc J. 2012. PMID: 23092777 Free PMC article.
-
Boswellia resin extract and propolis derived polyphenols in patients with type III chronic prostatitis/chronic pelvic pain syndrome: An Italian prospective multicenter study.Asian J Urol. 2022 Apr;9(2):139-145. doi: 10.1016/j.ajur.2021.09.002. Epub 2021 Sep 11. Asian J Urol. 2022. PMID: 35509480 Free PMC article.
-
[Intraprostatic botulinum toxin A injection in chronic prostatitis and chronic pelvic pain syndrome (CP/CPPS)].Urologe A. 2007 Sep;46(9):1030-2. doi: 10.1007/s00120-007-1384-8. Urologe A. 2007. PMID: 17605125 Clinical Trial. German. No abstract available.
-
Efficacy and Safety of Guihuang Formula in Treating Type III Prostatitis Patients with Dampness-Heat and Blood Stasis Syndrome: A Randomized Controlled Trial.Chin J Integr Med. 2022 Oct;28(10):879-884. doi: 10.1007/s11655-022-3467-1. Epub 2022 Apr 13. Chin J Integr Med. 2022. PMID: 35419726 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical